Finance

Lists
Why is AKTX down ८.३५%?
Dive Deeper
AKTX:NASDAQ
Akari Therapeutics PLC
US$ ७.२४
-८.३५%
(-०.६६) 1D
US$ ७.९६
+९.९४% (+०.७२)
After hours
Closed: अक्टोबर १४, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AKTX...
Open
US$ ८.१०
High
US$ ८.१०
Low
US$ ७.१९
Mkt. cap
१.६६ करोड
Avg. vol.
६९.४८ हजार
Volume
५०.००
52-wk high
US$ ३९.६४
52-wk low
US$ ३.०२
EPS
-US$ ३३०.४०
Beta
१.४३
Shares outstanding
११.४५ लाख
No. of employees
५
Open
US$ ८.१०
High
US$ ८.१०
Low
US$ ७.१९
Mkt. cap
१.६६ करोड
Avg. vol.
६९.४८ हजार
Volume
५०.००
52-wk high
US$ ३९.६४
52-wk low
US$ ३.०२
EPS
-US$ ३३०.४०
Beta
१.४३
Shares outstanding
११.४५ लाख
No. of employees
५
News stories
From web sources and news partners
About Akari Therapeutics PLC
CEO-
Employees५
Founded२००४
Headquartersताम्पा, फ्लोरिडा, संयुक्त राज्य अमेरिका
Sector-
Websiteakaritx.com
Analyst ratings
Based on 3 analysts giving stock ratings to AKTX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AKTX in the last 3 months.
Highest
Current US$ ७.२४
US$ ३०.०० (+३१४.३६%)
Average
US$ २५.५० (+२५२.२१%)
Lowest
US$ १९.५० (+१६९.३४%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
US$ २७.००
+२७२.९%
10/01/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
US$ १९.५०
+१६९.३%
09/16/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ३०.००
+३१४.४%
08/18/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
US$ ४०.००
+४५२.५%
01/05/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
US$ ७.००
-३.३%
11/19/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
२.४९ लाख
१०.८६ लाख
१४.५९ लाख
२०.७७ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१९.७५ लाख
२१.४१ लाख
२१.६९ लाख
२५.२५ लाख
Operating expense
२२.२४ लाख
३२.२७ लाख
३६.२८ लाख
४६.०२ लाख
Total operating expenses
२२.२४ लाख
३२.२७ लाख
३६.२८ लाख
४६.०२ लाख
Operating income
-२२.२४ लाख
-३२.२७ लाख
-३६.२८ लाख
-४६.०२ लाख
Other non operating income
२.५३ लाख
३१.९६ लाख
२.७४ लाख
-९९.०० हजार
EBT including unusual items
-७४.८८ लाख
-५२.१३ लाख
-१.५३ करोड
-४८.०७ लाख
EBT excluding unusual items
-२१.१५ लाख
-९.९८ लाख
-३३.५१ लाख
-४८.०७ लाख
Income tax expense
-१०.८८ लाख
८५.०० हजार
-८.५९ लाख
-
Effective tax rate
१४.५३%
-१.६३%
५.६१%
-
Other operating expenses
-
-
-
-
Net income
-६४.०० लाख
-५२.९८ लाख
-१.४५ करोड
-४८.०७ लाख
Net profit margin
-
-
-
-
Earnings per share
-१.०६
-
-
-
Interest and investment income
१.०० हजार
-
-
-
Interest expense
-१.२१ लाख
-७.२३ लाख
-६१.०० हजार
-८०.०० हजार
Net interest expenses
-१.२० लाख
-७.२३ लाख
-६१.०० हजार
-८०.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-२२.२० लाख
-३२.२४ लाख
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू